miR-7 modulates chemoresistance of small cell lung cancer by repressing MRP1/ABCC1

International Journal of Experimental Pathology

Volumn 96, Issue 4, 2015, Pages 240-247

  Liu, Huanxin ^a,b   Wu, Xiaoxia ^b   Huang, Jie ^a   Peng, Juan ^a   Guo, Linlang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; MiR 7; MRP1 ABCC1; SCLC

Indexed keywords

MICRORNA; MICRORNA 7; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; MIRN7 MICRORNA, HUMAN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER PATIENT; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL CELL LUNG CANCER; AGED; BIOLOGY; BIOSYNTHESIS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PROCEDURES;

ADULT; AGED; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMALL CELL LUNG CARCINOMA;

EID: 84939654334     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12131     Document Type: Article

References (33)

1. Bartel D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
2. Borel F. et al. (2012) Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 55, 821-832.
3. Chang X.B. (2007) A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer Metastasis Rev. 26, 15-37.
4. Cole S.P. et al. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
5. Fang Y. et al. (2012) MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology 55, 1852-1862.
6. Flens M.J. et al. (1996) Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148, 1237-1247.
7. Fornari F. et al. (2009) MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 69, 5761-5767.
8. Govindan R. et al. (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 24, 4539-4544.
9. Guo L. et al. (2010) Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur. J. Cancer 46, 1692-1702.
10. Hsia T.C. et al. (2002) Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression. Lung 180, 173-179.
11. Kefas B. et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68, 3566-3572.
12. Kong D. et al. (2012) Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 31, 3949-3960.
13. Kuo T.H. et al. (2003) To predict response chemotherapy using technetium-99 m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression. Nucl. Med. Biol. 30, 627-632.
14. Li P. et al. (2014) MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation. Biomed. Pharmacother. 68, 7-12.
15. Liang Z. et al. (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem. Pharmacol. 79, 817-824.
16. Mo W. & Zhang J.T. (2009) Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease. Expert Opin. Drug Metab. Toxicol. 5, 1049-1063.
17. Moitra K. et al. (2012) Differential gene and microRNA expression between etoposide resistant andetoposide sensitive MCF7 breast cancer cell lines. PLoS ONE 7, e45268.
18. Pan Y.Z. et al. (2013) Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1. Drug Metab. Dispos. 41, 1744-1751.
19. Rao X. et al. (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30, 1082-1097.
20. Reddy S.D. et al. (2008) MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 68, 8195-8200.
21. Sandler A.B. (2003) Chemotherapy for small cell lung cancer. Semin. Oncol. 30, 9-25.
22. Saydam O. et al. (2011) miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Res. 71, 852-861.
23. Skalsky R.L. & Cullen B.R. (2011) Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS ONE 6, e24248.
24. Song B. et al. (2009) Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28, 4065-4074.
25. St-Pierre M.V. et al. (2000) Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1495-R1503.
26. Triller N. et al. (2006) Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54, 235-240.
27. Valeri N. et al. (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc. Natl. Acad. Sci. U S A 107, 21098-21103.
28. Xiao F. et al. (2014) Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur. J. Cancer 50, 1541-1554.
29. Xiong S. et al. (2011) MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int. J. Biol. Sci. 7, 805-814.
30. Yang H. et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433.
31. Yin J. & Zhang J. (2011) Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application. Zhong. Nan Da Xue Xue Bao Yi Xue Ban 36, 927-938.
32. Yu Z. et al. (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J. Mol. Histol. 44, 669-677.
33. Zaman G.J. et al. (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res. 53, 1747-1750.